Joshua R Lamstein is Chairman of Scopus BioPharma Inc.. Currently has a direct ownership of 119,997 shares of SCPS, which is worth approximately $0. The most recent transaction as insider was on Aug 27, 2021, when has been sold 200 shares (Common Stock, par value $0.001) at a price of $5.0 per share, resulting in proceeds of $1,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 120K
0% 3M change
0% 12M change
Total Value Held $0

Joshua R Lamstein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 27 2021
BUY
Open market or private purchase
$1,000 $5.0 p/Share
200 Added 0.17%
119,997 Common Stock, par valu...
Aug 26 2021
BUY
Open market or private purchase
$980 $4.9 p/Share
200 Added 0.17%
119,797 Common Stock, par valu...
Aug 19 2021
BUY
Open market or private purchase
$3,232 $4.04 p/Share
800 Added 0.66%
119,597 Common Stock, par valu...
Jul 23 2021
BUY
Open market or private purchase
$7,065 $4.71 p/Share
1,500 Added 1.25%
118,797 Common Stock, par valu...
Feb 23 2021
BUY
Open market or private purchase
$4,670 $9.34 p/Share
500 Added 0.42%
117,297 Common Stock, par valu...
Feb 22 2021
BUY
Open market or private purchase
$999 $9.99 p/Share
100 Added 0.09%
116,797 Common Stock, par valu...
Feb 19 2021
BUY
Open market or private purchase
$5,465 $10.93 p/Share
500 Added 0.43%
116,697 Common Stock, par valu...
JRL

Joshua R Lamstein

Chairman
New York, NY

Track Institutional and Insider Activities on SCPS

Follow Scopus BioPharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SCPS shares.

Notify only if

Insider Trading

Get notified when an Scopus Bio Pharma Inc. insider buys or sells SCPS shares.

Notify only if

News

Receive news related to Scopus BioPharma Inc.

Track Activities on SCPS